The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water.
The proposed regulation sets an aggressive limit for these PFAS and their mixtures and acknowledges effects at extremely low levels by proposing a health based Maximum Contaminant Level Goal (MCGL) of zero. This is the first time the government has regulated a new chemical in drinking water in more than 30 years.
The new rule would require major water treatment upgrades at utilities across the country.
PFAS are manmade chemicals used as oil and water repellents and coatings for common products including cookware, carpets and textiles. PFAS chemicals can contaminate drinking water supplies near facilities where the chemicals are used.
These endocrine-disrupting chemicals do not break down when they are released into the environment, and they continue to accumulate over time. They pose health dangers at incredibly low levels and have been linked to endocrine disorders such as cancer, thyroid disruption and reproductive difficulties.
While this rule makes important progress towards reducing PFAS in drinking water to improve public health, continued vigilance and a more comprehensive class-based approach will remain necessary as PFAS comprise a large and complex class of chemicals.
You may also like
Endocrine Society Celebrates Special Diabetes Program Extension
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…
New Position Statement Focuses on Patient Experience in Diabetes Care
Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology &…